Correlia Biosystems Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
Series A1
- Latest Deal Amount
-
$1.25M
- Investors
-
16
Correlia Biosystems General Information
Description
Developer of a streamlined microscale assay platform designed to reduce the time and cost of quantifying proteins for proteomics and pharmaceutical applications. The company's platform provides multiplexing capabilities for large protein panels, including cytokines and post-translational modifications, with unparalleled speed and automation, enabling researchers to obtain large panel protein studies and reducing the cost and time to market for candidate drug compounds.
Contact Information
Website
correliabio.comCorporate Office
- 626 Bancroft Way
- Suite A
- Berkeley, CA 94710
- United States
Corporate Office
- 626 Bancroft Way
- Suite A
- Berkeley, CA 94710
- United States
Correlia Biosystems Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Later Stage VC (Series A1) | 09-May-2023 | $1.25M | Completed | Generating Revenue | ||
| 13. Later Stage VC (Series A) | 01-Oct-2020 | Completed | Generating Revenue | |||
| 12. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 11. Grant | 31-Jan-2020 | Completed | Generating Revenue | |||
| 10. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 9. Accelerator/Incubator | 19-Mar-2018 | Completed | Generating Revenue | |||
| 8. Grant | 01-Sep-2016 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 01-Nov-2014 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 01-Aug-2014 | $5K | Completed | Generating Revenue | ||
| 5. Grant | 01-Jul-2014 | $450K | $5K | Completed | Generating Revenue |
Correlia Biosystems Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A-3 | ||||||||
| Series A-2 | 1,091,449 | $0.000100 | 6% | $0.44 | $0.44 | 1x | $0.44 | 2.74% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Correlia Biosystems Comparisons
Industry
Financing
Details
Correlia Biosystems Competitors (2)
One of Correlia Biosystems’s 2 competitors is Preomics, a Venture Capital-Backed company based in Munich, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Preomics | Venture Capital-Backed | Munich, Germany | ||||
| ProMab Biotechnologies | Private Equity-Backed | Richmond, CA |
Correlia Biosystems Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Correlia Biosystems Patents
Correlia Biosystems Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260259243-A1 | Fluid removal for fluid sample processing systems | Pending | 27-Jun-2022 | ||
| WO-2024006301-A1 | Fluid removal for fluid sample processing systems | Inactive | 27-Jun-2022 | ||
| US-20250135452-A1 | Automated analyte measurement systems and kits for use therewith | Pending | 03-Feb-2022 | ||
| WO-2023150310-A1 | Automated analyte measurement systems and kits for use therewith | Inactive | 03-Feb-2022 | ||
| US-20250138040-A1 | System modules for use with fluid sample processing systems | Pending | 03-Feb-2022 | G01N35/1009 |
Correlia Biosystems Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Correlia Biosystems Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Endurance28 | Venture Capital | Minority | ||
| Freerun Ventures | Secondary Buyer | Minority | ||
| Baidu Ventures | Corporate Venture Capital | Minority | ||
| Beresford Ventures | Venture Capital | Minority | ||
| Blue Bear Ventures | Venture Capital | Minority |
Correlia Biosystems FAQs
-
When was Correlia Biosystems founded?
Correlia Biosystems was founded in 2013.
-
Where is Correlia Biosystems headquartered?
Correlia Biosystems is headquartered in Berkeley, CA.
-
What is the size of Correlia Biosystems?
Correlia Biosystems has 15 total employees.
-
What industry is Correlia Biosystems in?
Correlia Biosystems’s primary industry is Discovery Tools (Healthcare).
-
Is Correlia Biosystems a private or public company?
Correlia Biosystems is a Private company.
-
What is the current valuation of Correlia Biosystems?
The current valuation of Correlia Biosystems is .
-
What is Correlia Biosystems’s current revenue?
The current revenue for Correlia Biosystems is .
-
How much funding has Correlia Biosystems raised over time?
Correlia Biosystems has raised $11M.
-
Who are Correlia Biosystems’s investors?
Endurance28, Freerun Ventures, Baidu Ventures, Beresford Ventures, and Blue Bear Ventures are 5 of 16 investors who have invested in Correlia Biosystems.
-
Who are Correlia Biosystems’s competitors?
Preomics and ProMab Biotechnologies are competitors of Correlia Biosystems.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
